{"success":true,"data":{"pressRelease":{"id":"64462","rtpr_id":"nACSV1WFXa","ticker":"ADMA","exchange":"NASDAQ","all_tickers":["ADMA"],"title":"Recover Investment Losses: Class Action Initiated Against ADMA Biologics, Inc. (ADMA)","author":"ACCESSWIRE","published_at":"2026-06-16T06:10:00.213Z","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / June\n16, 2026 / Levi & Korsinsky, LLP announces that a securities class action\nlawsuit has been filed on behalf of investors who purchased or otherwise\nacquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities.\n\nIf you suffered a loss on your ADMA Biologics, Inc. investment and would like\nto explore a potential recovery under the federal securities laws, Learn about\nADMA Biologics, Inc. Class Action (https://pr.report/mn2c) or contact Joseph\nE. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to\nspeak to our team of experienced shareholder advocates.\n\nTHE LAWSUIT: A class action securities lawsuit was filed against ADMA\nBiologics, Inc. that seeks to recover losses of shareholders who were\nadversely affected by alleged securities fraud between August 9, 2024 and\nMarch 25, 2026.\n\nCASE DETAILS: The filed complaint alleges that defendants made false\nstatements and/or concealed that: (1) ADMA Biologics engaged in an undisclosed\nrelated party transaction; (2) ADMA Biologics used channel stuffing to create\nan appearance of revenue; (3) ADMA Biologics lacked adequate internal\ncontrols; (4) as a result, defendants' statements about ADMA Biologics'\nbusiness, operations, and prospects were materially false and misleading\nand/or lacked a reasonable basis at all relevant times.\n\nWHAT'S NEXT? If you purchased ADMA Biologics, Inc. stock during the relevant\ntime frame - even if you still hold your shares, learn about your rights to\nseek a recovery (https://pr.report/mn2d). There is no cost or obligation to\nparticipate.\n\nWHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has\nestablished itself as a nationally-recognized securities litigation firm that\nhas secured hundreds of millions of dollars for aggrieved shareholders and\nbuilt a track record of winning high-stakes cases. The firm has extensive\nexpertise representing investors in complex securities litigation and a team\nof over 70 employees to serve our clients. For seven years in a row, Levi &\nKorsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as\none of the top securities litigation firms in the United States. Attorney\nAdvertising. Prior results do not guarantee similar outcomes.\n\nCONTACT:\nLevi & Korsinsky, LLP\nJoseph E. Levi, Esq.\nEd Korsinsky, Esq.\n33 Whitehall Street, 27th Floor\nNew York, NY 10004\njlevi@levikorsinsky.com\nTel: (212)363-7500\nFax: (212) 363-7171\n\nSOURCE: Levi & Korsinsky, LLP\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/recover-investment-losses-class-action-initiated-against-adma-bi-1178025)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACSV1WFXa","title":"Recover Investment Losses: Class Action Initiated Against ADMA Biologics, Inc. (ADMA)","author":"ACCESSWIRE","ticker":"ADMA","created":"2026-06-16T06:10:00.213Z","tickers":["ADMA"],"exchange":"NASDAQ","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / June\n16, 2026 / Levi & Korsinsky, LLP announces that a securities class action\nlawsuit has been filed on behalf of investors who purchased or otherwise\nacquired ADMA Biologics, Inc. (NASDAQ:ADMA) securities.\n\nIf you suffered a loss on your ADMA Biologics, Inc. investment and would like\nto explore a potential recovery under the federal securities laws, Learn about\nADMA Biologics, Inc. Class Action (https://pr.report/mn2c) or contact Joseph\nE. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to\nspeak to our team of experienced shareholder advocates.\n\nTHE LAWSUIT: A class action securities lawsuit was filed against ADMA\nBiologics, Inc. that seeks to recover losses of shareholders who were\nadversely affected by alleged securities fraud between August 9, 2024 and\nMarch 25, 2026.\n\nCASE DETAILS: The filed complaint alleges that defendants made false\nstatements and/or concealed that: (1) ADMA Biologics engaged in an undisclosed\nrelated party transaction; (2) ADMA Biologics used channel stuffing to create\nan appearance of revenue; (3) ADMA Biologics lacked adequate internal\ncontrols; (4) as a result, defendants' statements about ADMA Biologics'\nbusiness, operations, and prospects were materially false and misleading\nand/or lacked a reasonable basis at all relevant times.\n\nWHAT'S NEXT? If you purchased ADMA Biologics, Inc. stock during the relevant\ntime frame - even if you still hold your shares, learn about your rights to\nseek a recovery (https://pr.report/mn2d). There is no cost or obligation to\nparticipate.\n\nWHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has\nestablished itself as a nationally-recognized securities litigation firm that\nhas secured hundreds of millions of dollars for aggrieved shareholders and\nbuilt a track record of winning high-stakes cases. The firm has extensive\nexpertise representing investors in complex securities litigation and a team\nof over 70 employees to serve our clients. For seven years in a row, Levi &\nKorsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as\none of the top securities litigation firms in the United States. Attorney\nAdvertising. Prior results do not guarantee similar outcomes.\n\nCONTACT:\nLevi & Korsinsky, LLP\nJoseph E. Levi, Esq.\nEd Korsinsky, Esq.\n33 Whitehall Street, 27th Floor\nNew York, NY 10004\njlevi@levikorsinsky.com\nTel: (212)363-7500\nFax: (212) 363-7171\n\nSOURCE: Levi & Korsinsky, LLP\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/recover-investment-losses-class-action-initiated-against-adma-bi-1178025)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-06-16T06:10:00.263339289Z","server_sent_at_ms":1781590200263},"received_at":"2026-06-16T06:10:00.321Z","source_url":"https://www.accessnewswire.com/newsroom/en/business-and-professional-services/recover-investment-losses-class-action-initiated-against-adma-bi-1178025"},"analysis":{"id":"53882","press_release_id":"64462","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Levi & Korsinsky, LLP announced a class action lawsuit against ADMA Biologics, Inc. on behalf of investors who purchased securities between August 9, 2024 and March 25, 2026.\n\nThe complaint alleges the company engaged in undisclosed related party transactions, used channel stuffing to inflate revenue, and lacked adequate internal controls.\n\nThis is a solicitation for affected shareholders to contact the firm to discuss potential recovery options at no cost or obligation.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":null,"quotedText":"A class action securities lawsuit was filed against ADMA Biologics, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between August 9, 2024 and March 25, 2026.","namedEntities":{"people":[{"name":"Joseph E. Levi, Esq."},{"name":"Ed Korsinsky, Esq."}],"products":[],"companies":[{"name":"Levi & Korsinsky, LLP","relationship":"plaintiff law firm"},{"name":"ADMA Biologics, Inc.","ticker":"ADMA"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Levi & Korsinsky. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"ADMA"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Levi & Korsinsky, LLP announced a class action lawsuit against ADMA Biologics, Inc. on behalf of investors who purchased securities between August 9, 2024 and March 25, 2026.\n\nThe complaint alleges the company engaged in undisclosed related party transactions, used channel stuffing to inflate revenue, and lacked adequate internal controls.\n\nThis is a solicitation for affected shareholders to contact the firm to discuss potential recovery options at no cost or obligation.","key_figures":null,"named_entities":{"people":[{"name":"Joseph E. Levi, Esq."},{"name":"Ed Korsinsky, Esq."}],"products":[],"companies":[{"name":"Levi & Korsinsky, LLP","relationship":"plaintiff law firm"},{"name":"ADMA Biologics, Inc.","ticker":"ADMA"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-06-16T06:24:41.139Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":113945,"modelName":"george-droid-qwen-72b"}}